Red Teaming vs Acceptance Tests: George Dagliyan Research Guide
Published: 2026-07-28 — Dr. George Dagliyan site editorial team. Editorial article.
A practical way to separate red teaming from acceptance testing, assign owners, and route findings into release decisions for generative AI systems.
This editorial guide connects public research and standards with George Dagliyan’s documented research themes. Checklists and examples are proposed here for illustration; they are not quotations or reported client results.
What problem does this comparison solve for AI release decisions?
George Dagliyan’s research themes on adoption, trust, and decision-making make this a useful operational question: when should a team treat a test as ordinary acceptance work, and when should it treat the same issue as a deliberate misuse discovery exercise? The short answer is that acceptance tests confirm ordinary task performance, while red teaming looks for harmful or unexpected behavior under stress. Both matter, but they answer different release questions.
This article uses the term red teaming to mean structured attempts to discover misuse, failure modes, or risky emergent behavior in a controlled setting. Acceptance testing means checking that a system performs agreed-upon ordinary tasks as intended, and regression evaluation means confirming that recent changes did not break previously working behavior. NIST’s AI RMF and its Generative AI Profile both place these activities inside a broader risk-management process rather than treating any one test as decisive.
How are red teaming, acceptance tests, and regression tests different?
Acceptance tests ask whether the system meets a defined requirement in normal use. A response generator may need to summarize a document, answer a support question, or format output in a required style; the point is to verify that the intended task works. Regression tests ask whether a new model, prompt, policy, or guardrail caused a previously passing behavior to fail.
Red teaming asks a different question: what happens when the system is pushed into boundary conditions, misuse patterns, or conflicts between instructions and safeguards? NIST’s AI RMF Playbook includes TEVV, meaning testing, evaluation, verification, and validation, as one of the activity areas, and the Playbook’s governance items emphasize that organizations should document risks, assign responsibilities, and establish monitoring. In practice, that means red teaming is not a substitute for acceptance testing, and acceptance testing is not a substitute for red teaming.
When should each test run in the release cycle?
A practical sequence is to run acceptance tests first for baseline readiness, then regression tests after each material change, and then red teaming before a release decision if the use case or risk profile warrants deeper scrutiny. That sequence helps separate routine product quality from misuse discovery. It also prevents a team from mistaking “the feature works” for “the system is robust enough for the intended context of use.”
NIST’s AI RMF and Generative AI Profile describe trustworthiness considerations across design, development, use, and evaluation, which supports a lifecycle view rather than a one-time gate. In this article’s editorial analysis, the release manager should treat red teaming as a higher-scrutiny activity when the system has broad reach, sensitive outputs, or a history of surprising behavior. Acceptance and regression testing should still occur even when red teaming is planned, because a model that fails basic tasks is not ready for misuse review.
Who owns the work, and how should findings move?
Ownership should be explicit. A product owner or delivery lead typically owns acceptance criteria, because that role is closest to the intended user task and business requirement. A test lead or QA function often owns regression suites, because those checks need repeatability across versions. A risk or governance owner should coordinate red teaming, because misuse discovery often produces issues that affect policy, release approval, and monitoring plans.
Findings should move through a simple routing path: task failures go to product and engineering; recurring breakages go to release management; misuse findings go to risk, governance, and the decision owner; and unresolved high-severity issues go to executive oversight. NIST’s Playbook states that roles and responsibilities and lines of communication should be documented and clear, and that executives take responsibility for decisions about AI system risks. This routing model is a proposed worksheet, not an official NIST process.
A worksheet for separating task failures from misuse findings
Use the following editorial worksheet for each test case. Column 1: test type, with one of three labels—acceptance, regression, or red team. Column 2: intended behavior, stated in plain language. Column 3: observed behavior. Column 4: severity, using a simple scale such as low, medium, or high. Column 5: owner, meaning the role responsible for action. Column 6: routing path, meaning who must review the issue next. Column 7: release impact, with three options: no change, fix before release, or escalate for decision.
Decision rule: if the issue is a basic requirement miss, route it as a task-quality defect. If the issue is a repeat failure caused by a recent change, route it as a regression defect. If the issue reveals misuse potential, harmful interaction, or a risky emergent behavior under unusual prompting or context, route it as a red-team finding. The rule is intentionally simple so that teams can apply it consistently before they debate technical nuance.
What does a worked hypothetical example look like?
Hypothetical scenario: a generative AI assistant helps employees draft internal policy summaries. Assumption 1: the release includes a new prompt template. Assumption 2: the organization has a defined summary format and a review workflow. Assumption 3: the release gate uses ordinary acceptance testing, regression checks, and a separate misuse review. These assumptions are fictional and are used only to show the process.
An acceptance test may confirm that the assistant returns a concise summary with required headings. A regression test may confirm that the same formatting still works after the prompt update. A red-team review may discover that the system, when given a confusing instruction, mixes policy content with unsupported claims. The task-quality defect goes to product and engineering, the repeated formatting break goes to the regression owner, and the misuse-related issue goes to the risk owner for a release decision. That separation prevents a single defect queue from obscuring the actual nature of the problem.
How should release decisions be made without overclaiming safety?
A release decision should be framed as “fit for this defined use under this defined control set,” not “safe in general.” That wording matters because NIST positions AI risk management as an ongoing process of measuring, managing, and improving trustworthiness, not as a one-time guarantee. Red teaming can strengthen confidence in a release decision, but it cannot prove safety across all contexts or future inputs.
A useful decision meeting should include three questions. First, are acceptance criteria met for the intended tasks? Second, do regression results show any newly introduced breakage? Third, did red teaming uncover issues that exceed the organization’s risk tolerance for the context of use? If the answer to any of these is no, the release owner should record the specific gap, the responsible owner, and the next review date.
How does this fit a broader adoption and governance strategy?
This article’s editorial analysis links the testing distinction to George Dagliyan’s documented research themes on technology acceptance, innovation diffusion, and adoption facilitators and inhibitors. Teams do not adopt AI because a model is impressive in a demo; they adopt it when trust, usability, and governance align well enough for the intended setting. Clear testing boundaries help organizations decide what is ready, what needs more work, and what should not be released yet.
NIST’s AI RMF Playbook emphasizes governance, mapping, measuring, and managing, which makes the testing strategy part of organizational decision-making rather than just a technical checklist. That is the practical lesson: acceptance testing protects task quality, regression testing protects continuity, and red teaming protects against misuse surprises. When those three are separated, owned, and routed well, release decisions become more disciplined and easier to explain.
Frequently Asked Questions
Can red teaming replace acceptance testing for a generative AI release?
No. Red teaming and acceptance testing answer different questions. Acceptance testing checks whether the system performs intended tasks in normal use, while red teaming looks for misuse, harmful edge cases, or risky emergent behavior. A release decision is stronger when both are present, because a system can pass one and still fail the other.
What is the main benefit of keeping regression tests separate from red teaming?
Regression tests tell the team whether a recent change broke something that used to work. Red teaming tells the team whether the system can be pushed into unsafe or misleading behavior under unusual conditions. Separating them prevents confusion in triage, helps owners respond faster, and makes release decisions easier to document clearly.
Who should own red-team findings in a release process?
A risk or governance owner should typically coordinate red-team findings because those issues often affect release approval, policy controls, and monitoring plans. Product and engineering may still need to fix the root cause, but the release-impact decision should not sit only with the team that built the feature. NIST’s Playbook supports clear roles and communication.
Does a strong red-team result prove the AI system is safe?
No. A strong red-team result can increase confidence, but it does not prove safety across all future contexts or inputs. NIST’s AI RMF treats risk management as an ongoing process of measuring, managing, and improving trustworthiness. The best practice is to record the scope of what was tested and avoid overclaiming beyond that scope.
What is a simple rule for routing issues after testing?
Route ordinary task misses to product and engineering, route repeated breakage after a change to the regression owner, and route misuse-related or harmful-behavior findings to risk or governance for a release decision. If the issue touches more than one category, assign one primary owner and one review path so the finding does not stall.